ACCESS Newswire
21 Nov 2023, 06:51 GMT+10
SEOUL, SOUTH KOREA / ACCESSWIRE / November 20, 2023 / Korea's leading adult stem cell research institute, Biostar Stem Cell Research Institute (Director: Dr. Jeongchan Ra), announced on the 20th that a regenerative medicine technology that treats Parkinson's disease by administering autologous fat-derived stem cells cultured using patented technology into the intravenous and spinal cord cavity has been approved by the Japanese Ministry of Health and Welfare and will begin treatment at the Shinjuku Clinic in Tokyo in December.
The approved stem cell treatment protocol involves administering 150 to 250 million fat-derived stem cells intravenously and 50 million cells into the spinal cord cavity five times at intervals of two to four weeks. The stem cells are either obtained from the Biostar Stem Cell Research Institute in Korea or from JASC, a Japanese affiliate.
The approval of stem cell treatment for Parkinson's disease marks a significant milestone in the clinical application of stem cells by the Biostar Stem Cell Research Institute, which began its research in 2008. The institute has previously received stem cell therapies for degenerative arthritis, severe lower extremity ischemia, and autoimmune diseases, administrated through intraarticular, intramuscular, and intravenous routes, respectively. The intravenous and spinal cord cavity administration of stem cells for Parkinson's disease further demonstrates the versatility and safety of Biostar's stem cell culture technology.
Stem cells vary greatly in safety and effectiveness depending on the culture method, highlighting the importance of rigorous quality management. The Biostar Stem Cell Research Institute's two-decade-long research on stem cell culture and treatment technologies, including the recently approved Parkinson's disease therapy, holds promise for developing new avenues for treating neurological disorders. The specialized culture media developed by the Biostar Stem Cell Research Institute, exclusively manufactured and supplied by its affiliate Nature Cell, plays a crucial role in enhancing the effectiveness and safety of these therapies.
The Biostar Stem Cell Research Institute is committed to expanding treatment-approved hospitals across Japan and intensifying global outreach, aiming to make Japan a destination for Parkinson's disease patients worldwide to regain their health.
Parkinson's disease affects an estimated 10 million people worldwide, with a rapidly growing prevalence, and remains an incurable condition without a definitive treatment.
Contact Information
Herim Park
Marketing Manager
[email protected]
+81-75-662-7171
Anna Woo
Marketing Manager
[email protected]
+81-75-662-7171
SOURCE: Biostar Stem Cell Research Institute
Get a daily dose of Japan Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Japan Herald.
More InformationTOKYO, Japan: Toyota is taking a fresh step toward autonomous driving by teaming up with Waymo to co-develop new vehicle platforms...
BEIJING, China: China's manufacturing sector lost steam in April, with activity shrinking at the fastest pace in over a year, as new...
Every day, police across Australia investigate thousands of incidents—any one of which could unlock a major case on the other side...
SYDNEY, Australia: A key measure of inflation in Australia has cooled to its lowest level in three years, lending weight to expectations...
HONG KONG: Hong Kong's housing market continued to lose ground in March, with home prices falling for a fourth straight month despite...
BEIJING, China: China's top airlines are still grounded in red ink, reporting steeper losses for the first quarter as they battle fierce...
TOKYO, Japan: Toyota is taking a fresh step toward autonomous driving by teaming up with Waymo to co-develop new vehicle platforms...
NEW YORK, New York - U.S. stocks were volatile Monday as the focus remained on tariffs, and the perceived lack of trade deals despite...
SEATTLE, Washington: Amazon.com is ramping up its delivery game in rural America, announcing a US$4 billion investment to grow its...
SEATTLE, Washington: Starbucks is shifting course on its store strategy—putting people ahead of machines. The coffee giant announced...
BEIJING, China: China's manufacturing sector lost steam in April, with activity shrinking at the fastest pace in over a year, as new...
SYDNEY, Australia: A key measure of inflation in Australia has cooled to its lowest level in three years, lending weight to expectations...